Artificial Intelligence within Clinical Systems

What to expect

Timely information, interactive format

Digital technologies and data are transformational for life science researchers, and the patients they serve. With the advent of artificial intelligence, people, organizations, and governments are interacting with the healthcare continuum differently than in the past. The need to successfully treat patients, while deriving value from the rich variability of information flowing in, the growing velocity of work and data, the increasing variety of source content, and simply the sheer volume in today’s modern clinical trial requires new thinking.

The answers lie in flexible, AI-enhanced architecture that can capture both current and future needs, driving intelligence in tasks from data ingestion and transformation, to data quality and predictive insight generation.

Online Agenda

Why you should attend

Life science is under pressure to demonstrate Value from the rich Variability, the growing Velocity, the increasing Variety, and the sheer Volume of data while ensuring the integrity of this data for compliance requirements of today’s modern clinical trial. The demand to improve business throughput with the required regulatory and technology rigor is driving innovation in data science. This roundtable includes a bi-directional discussion addressing new opportunities and challenges born from frontier technologies for clinical research, notably artificial intelligence. We will discuss how AI provides data and multi-disciplinary tools to create responsible, trustworthy intelligence that improves patient and business outcomes.

Meet the Panelists

The virtual boardroom will be lead by our expert panelists

Wendy Morahan

Senior Director, Clinical Data Analytics IQVIA Technologies

Gary Shorter

Head of Research and Development of AI into Products IQVIA Technologies

More about IQVIA Technologies:

More information

IQVIA’s Clinical Data Analytics Suite (CDAS) empowers life science organizations to harmonize complex and disconnected data and use AI/ML to draw smarter insights that improve clinical research outcomes for patients, sites, and sponsors. This cloud-based, modular platform anchors the clinical trial lifecycle by ingesting and standardizing previously disconnected research data for inquiry in a single, scalable repository. Customers derive actionable insights using analytics tools including biostatistics, rich visualizations, and reporting with pre-built KRIs and KPIs. Learn more about CDAS and other IQVIA technologies’ solutions and expertise at iqvia.com/oct

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Clinical Trials IQVIA

IQVIA Virtual Boardroom – 26th April 2022

IQVIA Technologies Virtual Boardrooms

Artificial Intelligence: How Can Clinical Systems Be More Effective, Improve Accuracy and Reduce Risk?

Virtual Boardroom

Timely information, interactive format

Online Agenda

Harnessing data stewardship, access, integration, and standardization in a globally secure and regulated AI adoption model. Ensuring the maintenance of AI for full explainability and rooting its original source for any retrospective review needed.

Generating faster, smarter insights by applying sophisticated machine analysis

Implementing purpose built Intelligent Apps with dedicated APIs (Application Programing Interfaces) tailored for clinical workflow improvement. Monitoring intelligence for drift/bias and reviewing the AI performance over time for optimization.

Why you should attend

Meet the Panelists

Wendy Morahan

Gary Shorter

More about IQVIA Technologies:

Further Information

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

Thrombosis

Rare Diseases

This is required field*

0-10

10-50

50-100

100-500

500+

This is required field*

This is required field*

Under £100,000

£100,000 - £500,000

£500,000 - £1,000,000

£1,000,000 - £5,000,000

£5,000,000 - £10,000,000

£10,000,000 +

This is required field*

This is required field*

Discovery to Development

Pre-Clinical

Phase 1

Phase 2

Phase 3